Page 60

Junio 2017

ARTÍCULO DE INVESTIGACIÓN Otero CM, Montes AO, García AN, et al. Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med 2005; 165 (11); 1274-9. 18. Reeves GR, Whellan DJ, Patel MJ, O’Connor CM, Duncan P, Eggebeen JD, et al. Comparison of frecuency of frailty and severely impaired physical function in patients 740 ≥ 60 years hospitalized with acute decompensated heart failure versus chronic stable heart failure with reduced and preserved left ventricular ejection fraction. Am J Cardiol 2016; 117 (12): 1953-8. 19. de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, Van Gilst WH, Hillege HL, et al. The fibrosis marker galectin-3 and outcome in the general population. J Intern Med 2012; 272 (1): 55-64. 20. Ho JE, Liu C, Lyass A, Courchesne P, Pencina MJ, Vasan RS, et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol 2012; 60 (14): 1249-56. 21. Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Galectin-3, cardiac structure Galectina-3 en insuficiencia cardiaca - V. Rossel et al and function, and long-term mortality in patients with acutely decompensated heart failure. Eur J Heart Fail 2010; 12 (8): 826-32. 22. Lok DJ, Lok SI, Bruggink-André de la Porte PW, Badings E, Lipsic E, Van Wijngaarden J, et al. Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure. Clin Res Cardiol 2013; 102 (2): 103-10. 23. Lok DJA, Van Der Meer P, la Porte de PWB-A, Lipsic E, Van Wijngaarden J, Hillege HL, et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 2010; 99 (5): 323-8. 24. de Boer RA, Daniels LB, Maisel AS, Januzzi JL. State of the Art: Newer biomarkers in heart failure. Eur J Heart Fail 2015; 17 (6): 559-69. 25. van der Velde AR, Gullestad L, Ueland T, Aukrust P, Guo Y, Adourian AS, et al. Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients with Heart Failure: Data from CORONA and COACH. Circ Heart Fail 2013; 6 (2): 219-26. Rev Med Chile 2017; 145: 734-740


Junio 2017
To see the actual publication please follow the link above